US Patent Issued to DAIICHI SANKYO on Aug. 25 for "Anti-CD3 antibody and molecules comprising the antibody" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,919, issued on Aug. 25, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo).

"Anti-CD3 antibody and molecules comprising the antibody" was invented by Tohru Takahashi (Tokyo), Chigusa Yoshimura (Tokyo), Shiho Kozuma (Tokyo), Kensuke Nakamura (Tokyo), Chikako Suzuki (Tokyo) and Junya Ichikawa (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel antibody binding to human CD3, and a molecule having antigen binding activity that includes the antibody.The present invention provides a novel antibody binding to human CD3, a molecule having antigen binding activity that includes the antibody, and a pharmaceutical comp...